Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar

Abstract Chronic phase-chronic myeloid leukemia (CP-CML) in Qatar presents unique epidemiological and clinical challenges compared with those in the Western population, including nearly half of the affected patients being under 40 years of age. Additionally, the high prevalence of cardiovascular com...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Rola Ghasoub, Anas Hamad, Susanna El Akiki, Shehab Fareed, Anil Ellahie, Omar Ismael, Mohamed A. Yassin
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Springer 2025-10-01
Schriftenreihe:	Discover Oncology
Schlagworte:	Leukemia, myeloid, chronic phase Asciminib Tyrosine kinase inhibitors Cardiovascular diseases Safety Middle east
Online-Zugang:	https://doi.org/10.1007/s12672-025-03759-7
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!